Companies with a Future performance score of at least 3, ordered by Future performance score.
AdAlta Limited, a drug discovery and development company, develops protein therapeutics.
Botanix Pharmaceuticals Limited, a clinical stage cannabinoid therapeutics company, develops therapeutics for serious skin diseases in Australia.
Cynata Therapeutics Limited, together with its subsidiaries, develops and commercializes a proprietary mesenchymal stem cell technology under the Cymerus brand for human therapeutic use in Australia.
Starpharma Holdings Limited engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide.
Ecofibre Limited, together with its subsidiaries, engages in breeding, growing, processing, and distributing hemp products in the United States and Australia.
Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines.
Telix Pharmaceuticals Limited, an oncology company, develops molecularly targeted radiation products for unmet needs in cancer care in Australia.
Opthea Limited, a biotechnology company, develops and commercializes therapies primarily for eye disease in Australia.
Immutep Limited, a biotechnology company, engages in the research, development, and commercialization of biological products.
MGC Pharmaceuticals Limited, a biopharmaceutical company, produces and supplies phytocannabinoid derived medicines in Australia, Slovenia, and other European countries.
Cann Group Limited engages in research and development, cultivation and production, manufacturing, clinical evaluation, processing, packaging, and distribution/supply of medicinal cannabis for a range of diseases and medical conditions in Australia.
Medical Developments International Limited manufactures and distributes pharmaceutical drugs, and medical and veterinary equipment.
Genetic Signatures Limited operates as a molecular diagnostic (MDx) company in North America and Australia.
Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing drugs for the treatment of severe genetic and skin disorders in Europe, the United States, and Singapore.
Probiotec Limited manufactures, markets, and distributes a range of prescription and over-the-counter pharmaceuticals, complementary medicines, and specialty ingredients in Australia and internationally.
Palla Pharma Limited produces and distributes narcotic raw materials, active pharmaceutical ingredients, and finished dosage formulations for pharmaceutical markets in Australia and Norway.